| 000 | 01603 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513184723.0 | ||
| 264 | 0 | _c19991026 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/43.1.105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavey, P | |
| 245 | 0 | 0 |
_aCost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cJan 1999 |
||
| 300 |
_a105-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBelgium |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLength of Stay _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xeconomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMupirocin _xadministration & dosage |
| 650 | 0 | 4 | _aPeritoneal Dialysis |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aCraig, A M | |
| 700 | 1 | _aHau, C | |
| 700 | 1 | _aMalek, M | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 43 _gno. 1 _gp. 105-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/43.1.105 _zAvailable from publisher's website |
| 999 |
_c10339531 _d10339531 |
||